Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?

Over the last six years, three GLP-1 drugs have been approved for children aged 10 and older with Type 2 diabetes. | Over the ...

People with a common personality trait practiced by as many as one in five Americans may see fewer lasting results from GLP-1 ...

People with obesity and diabetes who undergo bariatric surgery face a significantly lower risk for several adverse health outcomes vs. those treated with GLP-1s, new data show.“Surgery should not be ...

Eli Lilly's Mounjaro helped children and adolescents aged 10 to 17 years with type 2 diabetes manage their blood sugar better ...

Misleading promotions of GLP-1 and compounded semaglutide products are drawing renewed regulatory scrutiny over risk ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Weight loss can be a challenge, even for those who eat ...

The marketing-related warning letters uploaded Tuesday number nearly 70, though the majority target online pharmacies and ...

The largest and most comprehensive meta-analysis to date on glucagon-like peptide-1 (GLP-1) receptor agonists reveals ...

A new era of weight-loss treatment could soon trade needles for pills. Drugmakers behind GLP-1 injections like Wegovy and ...

A new study from Duke University School of Medicine is challenging long-standing views on blood sugar regulation—and pointing ...

The GLP-1 boom is making people desperate to get the pricey weight-loss drugs. They won't get the real medication in "GLP-1 patches," doctors warn.